Published in Ann Neurol on October 01, 1998
Cognition and mood in Parkinson's disease in subthalamic nucleus versus globus pallidus interna deep brain stimulation: the COMPARE trial. Ann Neurol (2009) 2.29
Subthalamic nucleus stimulation reverses mediofrontal influence over decision threshold. Nat Neurosci (2011) 2.26
Subthalamic nucleus neuronal firing rate increases with Parkinson's disease progression. Mov Disord (2011) 2.12
The role of glutamate transporters in neurodegenerative diseases and potential opportunities for intervention. Neurochem Int (2007) 2.11
The cerebellum and basal ganglia are interconnected. Neuropsychol Rev (2010) 1.70
Stimulation of subterritories of the subthalamic nucleus reveals its role in the integration of the emotional and motor aspects of behavior. Proc Natl Acad Sci U S A (2007) 1.66
Deep brain stimulation of the subthalamic nucleus in Parkinson's disease: effects of variation in stimulation parameters. J Neurol Neurosurg Psychiatry (2001) 1.55
Deep brain stimulation for Parkinson's disease. Neurotherapeutics (2008) 1.53
Stimulation-induced inhibition of neuronal firing in human subthalamic nucleus. Exp Brain Res (2004) 1.51
Identification of the subthalamic nucleus in deep brain stimulation surgery with a novel wavelet-derived measure of neural background activity. J Neurosurg (2009) 1.49
The effects of chronic levodopa treatments on the neuronal firing properties of the subthalamic nucleus and substantia nigra reticulata in hemiparkinsonian rhesus monkeys. Exp Neurol (2010) 1.47
Effect of globus pallidus internus stimulation on neuronal activity in the pedunculopontine tegmental nucleus in the primate model of Parkinson's disease. Exp Neurol (2011) 1.46
Using point process models to compare neural spiking activity in the subthalamic nucleus of Parkinson's patients and a healthy primate. IEEE Trans Biomed Eng (2010) 1.41
Deep brain stimulation of the subthalamic nucleus: anatomical, neurophysiological, and outcome correlations with the effects of stimulation. J Neurol Neurosurg Psychiatry (2002) 1.40
Animal models of Parkinson's disease: a source of novel treatments and clues to the cause of the disease. Br J Pharmacol (2011) 1.39
Bilateral stimulation of the subthalamic nucleus has differential effects on reactive and proactive inhibition and conflict-induced slowing in Parkinson's disease. Exp Brain Res (2013) 1.36
Brain penetration effects of microelectrodes and DBS leads in STN or GPi. J Neurol Neurosurg Psychiatry (2009) 1.24
Subthalamic nucleus neurons are synchronized to primary motor cortex local field potentials in Parkinson's disease. J Neurosci (2013) 1.17
Deep brain stimulation of the subthalamic nucleus in Parkinson's disease: evaluation of active electrode contacts. J Neurol Neurosurg Psychiatry (2003) 1.17
Subthalamic nucleus stimulation in Parkinson's disease : anatomical and electrophysiological localization of active contacts. J Neurol (2006) 1.10
Human pallidothalamic and cerebellothalamic tracts: anatomical basis for functional stereotactic neurosurgery. Brain Struct Funct (2008) 1.10
Deep brain stimulation in early stage Parkinson's disease: operative experience from a prospective randomised clinical trial. J Neurol Neurosurg Psychiatry (2011) 1.08
Closing the loop of deep brain stimulation. Front Syst Neurosci (2013) 1.07
Reassessing models of basal ganglia function and dysfunction. Annu Rev Neurosci (2014) 1.04
Firing rates of pallidal neurons are similar in Huntington's and Parkinson's disease patients. Exp Brain Res (2005) 1.00
The subthalamic nucleus in primary dystonia: single-unit discharge characteristics. J Neurophysiol (2009) 1.00
Pedunculopontine nucleus microelectrode recordings in movement disorder patients. Exp Brain Res (2008) 0.99
Long-term experience with intraoperative microrecording during DBS neurosurgery in STN and GPi. Acta Neurochir (Wien) (2010) 0.99
Immunotoxin-mediated tract targeting in the primate brain: selective elimination of the cortico-subthalamic "hyperdirect" pathway. PLoS One (2012) 0.95
Customized, miniature rapid-prototype stereotactic frames for use in deep brain stimulator surgery: initial clinical methodology and experience from 263 patients from 2002 to 2008. Stereotact Funct Neurosurg (2010) 0.94
Extrastriatal dopaminergic circuits of the Basal Ganglia. Front Neuroanat (2010) 0.92
Apomorphine reduces subthalamic neuronal entropy in parkinsonian patients. Exp Neurol (2010) 0.91
Timing and direction selectivity of subthalamic and pallidal neurons in patients with Parkinson disease. Exp Brain Res (2005) 0.91
Teaching neurons to respond to placebos. J Physiol (2016) 0.89
MRI directed bilateral stimulation of the subthalamic nucleus in patients with Parkinson's disease. J Neurol Neurosurg Psychiatry (2003) 0.88
Basal ganglia dysfunction in OCD: subthalamic neuronal activity correlates with symptoms severity and predicts high-frequency stimulation efficacy. Transl Psychiatry (2011) 0.88
High-frequency microstimulation in human globus pallidus and substantia nigra. Exp Brain Res (2010) 0.86
Eye movement-related responses of neurons in human subthalamic nucleus. Exp Brain Res (2004) 0.86
Asymmetric right/left encoding of emotions in the human subthalamic nucleus. Front Syst Neurosci (2013) 0.84
Multiple conductances are modulated by 5-HT receptor subtypes in rat subthalamic nucleus neurons. Neuroscience (2007) 0.84
Multicenter study report: electrophysiological monitoring procedures for subthalamic deep brain stimulation surgery in Parkinson's disease. Neurol Sci (2010) 0.84
Influence of propofol and fentanyl on deep brain stimulation of the subthalamic nucleus. J Korean Med Sci (2014) 0.82
Standard guidelines for publication of deep brain stimulation studies in Parkinson's disease (Guide4DBS-PD). Mov Disord (2010) 0.81
Stimulation of contacts in ventral but not dorsal subthalamic nucleus normalizes response switching in Parkinson's disease. Neuropsychologia (2013) 0.80
Memantine block depends on agonist presentation at the NMDA receptor in substantia nigra pars compacta dopamine neurones. Neuropharmacology (2013) 0.80
Characterizing the spiking dynamics of subthalamic nucleus neurons in Parkinson's disease using generalized linear models. Front Integr Neurosci (2012) 0.80
Fully automated targeting using nonrigid image registration matches accuracy and exceeds precision of best manual approaches to subthalamic deep brain stimulation targeting in Parkinson disease. Neurosurgery (2015) 0.79
Local field potential recordings in a non-human primate model of Parkinsons disease using the Activa PC + S neurostimulator. J Neural Eng (2015) 0.79
The emergence of single neurons in clinical neurology. Neuron (2015) 0.79
Involvement of dopamine loss in extrastriatal basal ganglia nuclei in the pathophysiology of Parkinson's disease. Front Aging Neurosci (2014) 0.79
Identification of target areas for deep brain stimulation in human basal ganglia substructures based on median nerve sensory evoked potential criteria. J Neurol Neurosurg Psychiatry (2003) 0.79
The effects of cues on neurons in the basal ganglia in Parkinson's disease. Front Integr Neurosci (2012) 0.78
PPNa-DBS for gait and balance disorders in Parkinson's disease: a double-blind, randomised study. J Neurol (2015) 0.78
Lesion of subthalamic nucleus in parkinsonian rats : effects of dopamine d(1) and d(2) receptor agonists on the neuronal activities of the substantia nigra pars reticulata. J Korean Neurosurg Soc (2007) 0.78
Basal ganglia neuronal activity during scanning eye movements in Parkinson's disease. PLoS One (2013) 0.78
Antiparkinsonian potential of targeting group III metabotropic glutamate receptor subtypes in the rodent substantia nigra pars reticulata. Br J Pharmacol (2012) 0.78
The T-type calcium channel as a new therapeutic target for Parkinson's disease. Pflugers Arch (2014) 0.78
Treatment and physiology in Parkinson's disease and dystonia: using transcranial magnetic stimulation to uncover the mechanisms of action. Curr Neurol Neurosci Rep (2014) 0.77
Gene therapy for the treatment of Parkinson's disease: the nature of the biologics expands the future indications. Pharmaceuticals (Basel) (2012) 0.77
Lateral ventricle volume is poor predictor of post unilateral DBS motor change for Parkinson's disease. Parkinsonism Relat Disord (2011) 0.77
Dopaminergic control of the globus pallidus through activation of D2 receptors and its impact on the electrical activity of subthalamic nucleus and substantia nigra reticulata neurons. PLoS One (2015) 0.76
Contribution of inter-muscular synchronization in the modulation of tremor intensity in Parkinson's disease. J Neuroeng Rehabil (2015) 0.76
Prediction of STN-DBS Electrode Implantation Track in Parkinson's Disease by Using Local Field Potentials. Front Neurosci (2016) 0.76
Point process modeling reveals anatomical non-uniform distribution across the subthalamic nucleus in Parkinson's disease. Conf Proc IEEE Eng Med Biol Soc (2012) 0.75
Subthalamic Neurons Encode Both Single- and Multi-Limb Movements in Parkinson's Disease Patients. Sci Rep (2017) 0.75
Applying Microelectrode Recordings in Neurosurgery. Contemp Neurosurg (2010) 0.75
Altered Neuronal Firing Pattern of the Basal Ganglia Nucleus Plays a Role in Levodopa-Induced Dyskinesia in Patients with Parkinson's Disease. Front Hum Neurosci (2015) 0.75
Bilateral Deep Brain Stimulation of the Subthalamic Nucleus under Sedation with Propofol and Fentanyl. PLoS One (2016) 0.75
Depth-time interpolation of feature trends extracted from mobile microelectrode data with kernel functions. Stereotact Funct Neurosurg (2012) 0.75
Antiarrhythmics cure brain arrhythmia: The imperativeness of subthalamic ERG K(+) channels in parkinsonian discharges. Sci Adv (2017) 0.75
Dopamine D1 Receptor-Mediated Transmission Maintains Information Flow Through the Cortico-Striato-Entopeduncular Direct Pathway to Release Movements. Cereb Cortex (2015) 0.75
Validity of single tract microelectrode recording in subthalamic nucleus stimulation. Neurol Med Chir (Tokyo) (2013) 0.75
Using "Functional" Target Coordinates of the Subthalamic Nucleus to Assess the Indirect and Direct Methods of the Preoperative Planning: Do the Anatomical and Functional Targets Coincide? Brain Sci (2016) 0.75
High frequency deep brain stimulation of the subthalamic nucleus versus continuous subcutaneous apomorphine infusion therapy: a review. J Neural Transm (Vienna) (2010) 0.75
Deep brain stimulation: overview and update. J Clin Monit Comput (2006) 0.75
Subthalamic Nucleus Deep Brain Stimulation: Basic Concepts and Novel Perspectives. eNeuro (2017) 0.75
Movement-Related Activity of Human Subthalamic Neurons during a Reach-to-Grasp Task. Front Hum Neurosci (2017) 0.75
Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling. Nature (2000) 64.32
Rituximab chimeric anti-CD20 monoclonal antibody therapy for relapsed indolent lymphoma: half of patients respond to a four-dose treatment program. J Clin Oncol (1998) 8.40
Neuropathic pain: redefinition and a grading system for clinical and research purposes. Neurology (2007) 8.08
Two populations of Ia-like molecules on a human B cell line. J Immunol (1980) 7.68
Multicenter analysis of glucocerebrosidase mutations in Parkinson's disease. N Engl J Med (2009) 7.53
The genome of the natural genetic engineer Agrobacterium tumefaciens C58. Science (2001) 6.90
A five-year study of the incidence of dyskinesia in patients with early Parkinson's disease who were treated with ropinirole or levodopa. N Engl J Med (2000) 6.21
Deep-brain stimulation of the subthalamic nucleus or the pars interna of the globus pallidus in Parkinson's disease. N Engl J Med (2001) 6.07
Parkinson's disease. First of two parts. N Engl J Med (1998) 5.90
'Gene shaving' as a method for identifying distinct sets of genes with similar expression patterns. Genome Biol (2000) 5.29
Consensus statement on the diagnosis of multiple system atrophy. J Neurol Sci (1999) 5.01
IDEC-C2B8 (Rituximab) anti-CD20 monoclonal antibody therapy in patients with relapsed low-grade non-Hodgkin's lymphoma. Blood (1997) 4.97
Expression of endothelin-1 in the lungs of patients with pulmonary hypertension. N Engl J Med (1993) 4.91
Bilateral deep brain stimulation in Parkinson's disease: a multicentre study with 4 years follow-up. Brain (2005) 4.33
IDEC-C2B8: results of a phase I multiple-dose trial in patients with relapsed non-Hodgkin's lymphoma. J Clin Oncol (1997) 4.32
Vaccination of patients with B-cell lymphoma using autologous antigen-pulsed dendritic cells. Nat Med (1996) 4.15
The Lewy-body variant of Alzheimer's disease. Clinical and pathological findings. Br J Psychiatry (1993) 3.95
Treatment of B-cell lymphoma with monoclonal anti-idiotype antibody. N Engl J Med (1982) 3.78
Studies of a human T lymphocyte antigen recognized by a monoclonal antibody. Proc Natl Acad Sci U S A (1981) 3.63
Parkinson's disease. Second of two parts. N Engl J Med (1998) 3.46
Obliquity-paced Pliocene West Antarctic ice sheet oscillations. Nature (2009) 3.42
Posteroventral medial pallidotomy in advanced Parkinson's disease. N Engl J Med (1997) 3.23
Anatomical connectivity of the subgenual cingulate region targeted with deep brain stimulation for treatment-resistant depression. Cereb Cortex (2007) 2.83
Practice parameter: initiation of treatment for Parkinson's disease: an evidence-based review: report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology (2002) 2.81
Utility of an objective dyskinesia rating scale for Parkinson's disease: inter- and intrarater reliability assessment. Mov Disord (1994) 2.77
Induction of immune responses in patients with B-cell lymphoma against the surface-immunoglobulin idiotype expressed by their tumors. N Engl J Med (1992) 2.73
Measuring client gains from staff-implemented programs. J Appl Behav Anal (1978) 2.72
Prevalence of repetitive and reward-seeking behaviors in Parkinson disease. Neurology (2006) 2.70
Tacrine in Alzheimer's disease. Lancet (1991) 2.67
Randomized, double-blind trial of glial cell line-derived neurotrophic factor (GDNF) in PD. Neurology (2003) 2.65
Idiotype/granulocyte-macrophage colony-stimulating factor fusion protein as a vaccine for B-cell lymphoma. Nature (1993) 2.62
TAPA-1, the target of an antiproliferative antibody, defines a new family of transmembrane proteins. Mol Cell Biol (1990) 2.60
The anatomical basis of symptomatic hemidystonia. Brain (1985) 2.60
Superantigen antagonist protects against lethal shock and defines a new domain for T-cell activation. Nat Med (2000) 2.55
How does parkinsonism start? Prodromal parkinsonism motor changes in idiopathic REM sleep behaviour disorder. Brain (2012) 2.52
Detection of T and B cell antigens hybridoma monoclonal antibodies: a biotin-avidin-horseradish peroxidase method. J Histochem Cytochem (1980) 2.52
Frontal lobe dysfunction in Parkinson's disease. The cortical focus of neostriatal outflow. Brain (1986) 2.52
Phase I clinical trial using escalating single-dose infusion of chimeric anti-CD20 monoclonal antibody (IDEC-C2B8) in patients with recurrent B-cell lymphoma. Blood (1994) 2.48
Effect of GPi pallidotomy on motor function in Parkinson's disease. Lancet (1995) 2.47
Complete genome sequence of the genetically tractable hydrogenotrophic methanogen Methanococcus maripaludis. J Bacteriol (2004) 2.47
Prospective study to determine clinical relevance of detection of pneumococcal DNA in sera of children by PCR. J Clin Microbiol (1998) 2.42
The lymphochip: a specialized cDNA microarray for the genomic-scale analysis of gene expression in normal and malignant lymphocytes. Cold Spring Harb Symp Quant Biol (1999) 2.40
Rituximab anti-CD20 monoclonal antibody therapy in non-Hodgkin's lymphoma: safety and efficacy of re-treatment. J Clin Oncol (2000) 2.38
Expression of a single gene, BCL-6, strongly predicts survival in patients with diffuse large B-cell lymphoma. Blood (2001) 2.35
Mirror movements in parkinsonism: evaluation of a new clinical sign. J Neurol Neurosurg Psychiatry (2005) 2.35
Increased striatal dopamine release in Parkinsonian patients with pathological gambling: a [11C] raclopride PET study. Brain (2009) 2.35
A comparative study of visuospatial memory and learning in Alzheimer-type dementia and Parkinson's disease. Brain (1988) 2.32
The neural system that bridges reward and cognition in humans: an fMRI study. Proc Natl Acad Sci U S A (2002) 2.26
Neuropsychological consequences of chronic bilateral stimulation of the subthalamic nucleus in Parkinson's disease. Brain (2000) 2.25
Ongoing immunoglobulin somatic mutation in germinal center B cell-like but not in activated B cell-like diffuse large cell lymphomas. Proc Natl Acad Sci U S A (2000) 2.24
The pedunculopontine nucleus and Parkinson's disease. Brain (2000) 2.21
Double-blind evaluation of subthalamic nucleus deep brain stimulation in advanced Parkinson's disease. Neurology (1998) 2.19
Subthalamic deep brain stimulation at individualized frequencies for Parkinson disease. Neurology (2012) 2.18
Hemichorea-hemiballism associated with hyperglycemia and a developmental venous anomaly. Neurology (2012) 2.14
Optimization of quantitative real-time RT-PCR parameters for the study of lymphoid malignancies. Leukemia (2003) 2.12
Carbon monoxide re-breathing during low-flow anaesthesia in infants and children. Br J Anaesth (2010) 2.09
Arm levitation in progressive supranuclear palsy. Neurology (1999) 2.06
Rescue of immunoglobulin secretion from human neoplastic lymphoid cells by somatic cell hybridization. Proc Natl Acad Sci U S A (1978) 2.06
Cortical-basal ganglionic degeneration. Neurology (1990) 2.04
Hurthle cell carcinoma of the thyroid gland. A tumor of moderate malignancy. Cancer (1986) 2.04
High-frequency synchronization of neuronal activity in the subthalamic nucleus of parkinsonian patients with limb tremor. J Neurosci (2000) 2.04
Psychiatric phenomena in Alzheimer's disease. I: Disorders of thought content. Br J Psychiatry (1990) 2.01
The monoclonality of human B-cell lymphomas. J Exp Med (1977) 1.97
Tumor-specific idiotype vaccines in the treatment of patients with B-cell lymphoma--long-term results of a clinical trial. Blood (1997) 1.96
Corticobasal degeneration and progressive supranuclear palsy share a common tau haplotype. Neurology (2001) 1.95
A human thymus-leukemia antigen defined by hybridoma monoclonal antibodies. Proc Natl Acad Sci U S A (1979) 1.94
Lewy bodies and response to tacrine in Alzheimer's disease. Lancet (1994) 1.94
The effects of nicotine on attention, information processing, and short-term memory in patients with dementia of the Alzheimer type. Br J Psychiatry (1989) 1.94
Pain-related neurons in the human cingulate cortex. Nat Neurosci (1999) 1.92
Clustering of extensive somatic mutations in the variable region of an immunoglobulin heavy chain gene from a human B cell lymphoma. Cell (1986) 1.92
Impaired lymphocyte function in untreated Hodgkin's disease. N Engl J Med (1974) 1.91
Therapy of B-cell lymphoma with anti-CD20 antibodies can result in the loss of CD20 antigen expression. Clin Cancer Res (1999) 1.91
A clinical trial of anti-idiotype therapy for B cell malignancy. Blood (1985) 1.91
Phenotype in parkinsonian and nonparkinsonian LRRK2 G2019S mutation carriers. Neurology (2011) 1.90
Pathophysiologic mechanisms of acute graft-vs.-host disease. Biol Blood Marrow Transplant (1999) 1.90
Sustained increases in CD4 cell counts in asymptomatic human immunodeficiency virus type 1-seropositive patients treated with prednisolone for 1 year. J Infect Dis (1995) 1.88
Tardive dystonia: late-onset and persistent dystonia caused by antipsychotic drugs. Neurology (1982) 1.88
Complications of intracranial pressure monitoring in fulminant hepatic failure. Lancet (1993) 1.87
Globus pallidus stimulation activates the cortical motor system during alleviation of parkinsonian symptoms. Nat Med (1997) 1.85
Accuracy of clinical diagnosis of Alzheimer's disease. BMJ (1990) 1.84
Cognitive performance in tests sensitive to frontal lobe dysfunction in the elderly depressed. Psychol Med (1996) 1.84
DJ-1 (PARK7) mutations are less frequent than Parkin (PARK2) mutations in early-onset Parkinson disease. Neurology (2004) 1.83
Phantom sensations generated by thalamic microstimulation. Nature (1998) 1.83
Exercise training for rehabilitation and secondary prevention of falls in geriatric patients with a history of injurious falls. J Am Geriatr Soc (2001) 1.82
Clonal evolution of a follicular lymphoma: evidence for antigen selection. Proc Natl Acad Sci U S A (1992) 1.82
The hepatitis B virus X gene potentiates c-myc-induced liver oncogenesis in transgenic mice. Oncogene (1997) 1.81
Early medical use of cannabis. Nature (1993) 1.80
Cytosine arabinoside with daunorubicin or adriamycin for therapy of acute myelocytic leukemia: a CALGB study. Blood (1982) 1.79
Drug-induced deactivation of inhibitory networks predicts pathological gambling in PD. Neurology (2010) 1.79